Comparing Jinteli vs Prempro
| Jinteli (ethinyl estradiol / norethindrone) | Prempro (conjugated estrogens / medroxyprogesterone) |
|
|---|
| Jinteli (ethinyl estradiol / norethindrone) | Prempro (conjugated estrogens / medroxyprogesterone) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Postmenopausal Symptoms, Prevention of Osteoporosis. Jinteli may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Postmenopausal Symptoms, Osteoporosis, Atrophic Vaginitis, Atrophic Urethritis, Oophorectomy, Primary Ovarian Failure. Prempro may also be used for purposes not listed in this medication guide. View more |
||||||||||||||||
| More about Jinteli (ethinyl estradiol / norethindrone) | More about Prempro (conjugated estrogens / medroxyprogesterone) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Be the first to share your experience with this drug. |
Prempro has an average rating of 6.9 out of 10 from a total of 67 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Jinteli side effects |
View all Prempro side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Jinteli prices |
View all Prempro prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other ethinyl estradiol / norethindrone brands include: Alyacen 1/35, Alyacen 7/7/7, Aranelle, Aurovela 1.5/30, Aurovela 1/20, Aurovela 24 Fe, Aurovela Fe 1.5/30, Aurovela Fe 1/20, Balziva, Blisovi 24 Fe, Blisovi Fe 1.5/30, Blisovi Fe 1/20, Briellyn, Chabelina Fe, Charlotte 24 Fe, Cyonanz, Dasetta 1/35, Dasetta 7/7/7, Estrostep Fe, Feirza 1.5/30, Feirza 1/20, Femcon Fe, femhrt, Femlyv, Finzala, Fyavolv, Galbriela, Gemmily, Generess Fe, Gildagia, Gildess 1.5/30, Gildess 1/20, Gildess 24 Fe, Gildess Fe 1.5/30, Gildess Fe 1/20, Hailey 1.5/30, Hailey 24 Fe, Hailey Fe 1.5/30, Hailey Fe 1/20, Junel 1.5/30, Junel 1/20, Junel Fe 1.5/30, Junel Fe 1/20, Junel Fe 24, Kaitlib Fe, Larin 1.5/30, Larin 1/20, Larin 24 Fe, Larin Fe 1.5/30, Larin Fe 1/20, Layolis Fe, Leena, Leribane, Lo Loestrin Fe, Loestrin 21 1/20, Lomedia 24 Fe, Melodetta 24 Fe, Merzee, Mibelas 24 Fe, Microgestin 1.5/30, Microgestin 1/20, Microgestin Fe 1.5/30, Microgestin Fe 1/20, Minastrin 24 Fe, Necon 0.5/35, Necon 7/7/7, Nexesta Fe, Norinyl 1+35, Nortrel 0.5/35, Nortrel 1/35, Nortrel 7/7/7, Nylia 1/35, Nylia 7/7/7, Ortho-Novum 7/7/7, Oshih, Philith, Pirmella 1/35, Pirmella 7/7/7, Rhuzdah, Tarina 24 Fe, Tarina Fe 1/20 EQ, Taysofy, Taytulla, Tilia Fe, Tri-Legest Fe, Vyfemla, Wera, Wymzya Fe, Xarah Fe, Xelria Fe, Zenchent, Zenchent Fe View more | Other conjugated estrogens / medroxyprogesterone brands include: Premphase, Premphase 14/14 | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
14 hours |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 495 drugs are known to interact with Jinteli:
|
A total of 315 drugs are known to interact with Prempro:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
November 17, 1995 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.